Provided is a compound activating RORα gene, particularly a JC1 compound containing CGP52608 thiazolidinedione as a lead substance, and a pharmaceutically acceptable salt thereof. The compound is a lipid accumulation inhibitor and applicable to the treatment of metabolic diseases or inflammatory diseases.
提供的是一种激活RORα
基因的化合物,特别是一种含有CGP52608
噻唑烷二酮作为主要物质的JC1化合物,以及其药用盐。该化合物是一种脂肪积聚
抑制剂,适用于治疗代谢性疾病或炎症性疾病。